Inventor · disambiguated record
Michael Yeadon
Also filed as: YEADON MICHAEL
4 granted patents·12 pending applications·20 citations·filing 2002–2017
71Inventor score
Files withBOEHRINGER INGELHEIM PHARMA4PFIZER3ZIARCO PHARMA LTD3BOEHRINGE INGELHEIM PHARMA GMB1NOVARTIS AG1
Top patents by PatentIndex Score
16 records- 0176US9693995B2Pharmaceutical composition for topical administrationZIARCO PHARMA LTD·Filed 2015·Granted Jul 4, 2017·4 cites·17 claims
- 0276US6974803B2Pharmaceutical combinationPFIZER·Filed 2002·Granted Dec 13, 2005·14 cites·30 claims
- 0368US7107985B2Pharmaceutical combinationPFIZER·Filed 2005·Granted Sep 19, 2006·1 cites·6 claims
- 0467US10034858B2Pharmaceutical composition for topical administrationZIARCO PHARMA LTD·Filed 2017·Granted Jul 31, 2018·1 cites·21 claims
- 0554US2005250730A1Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 0654US2005209185A1Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 0749US2005107420A1Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseasesBOEHRINGE INGELHEIM PHARMA GMB·Filed 2003·Application pending·0 cites
- 0848US2019135787A1Pyrimidine compositions, ultra-pure compositions and salts thereof, methods of making the same, and methods of using the same for treating histamine h4 receptor (h4) mediated diseases and conditionsNOVARTIS AG·Filed 2016·Application pending·0 cites
- 0947US2003013675A1Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Application pending·0 cites
- 1046US2004167153A1Pharmaceutical combinationPFIZER·Filed 2003·Application pending·0 cites
- 1142US2004171576A1Adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseasesFiled 2002·Application pending·0 cites
- 1241US2003119862A1Pharmaceutical combinationFiled 2002·Application pending·0 cites
- 1341US2017158671A1Pyrimidine compositions, ultra pure compositions and salts thereof, methods of making the same, and methods of using the same for treating histamine h4 receptor (h4) mediated diseases and conditionsZIARCO PHARMA LTD·Filed 2016·Application pending·0 cites
- 1440US2007117788A1Combination of a dopamine D2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways and other inflammatory diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 1537US2004147544A1Pde4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseasesYEADON MICHAEL·Filed 2002·Application pending·0 cites
- 1635US2003109485A1Pharmaceutical combinationFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Yeadon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →